Clinical TrialsSearch results
Number of results: 321
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Compliance Survey of Multiple Oral Antibiotics
- Outpatients who are diagnosed Upper respiratory inflammation Lower respiratory inflammation and Otitis
- Nagasaki evaluation organization for clinical interventions
- 2009-07-22
Other
- Detection of abnormal sound by digitization of respiratory sounds
- respiratory diseases
- Toshi Eria Kiagi
- 2009-04-01
Other
- Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX SIRIUS STUDY I (the IFX-SIRIUS STUDY II): Study protocol for an interventional, multicenter ,open label, single arm clinical trial with clinical, ultrasound and biomarker assessments
- Rheumatoid arthritis
- Kawakami Atsushi
- 2020-04-20
Other
- Discontinuation of infliximab therapy after acquisition of low disease activity by infliximab in rheumatoid arthritis study: RRR (remission induction by remicade) study
- rheumatoid arthritis
- University of Occupational & Environmental Health, Japan
- 2009-06-23
Recruiting
- Discontinuation of methotrexate in rheumatoid arthritis patients achieving clinical remission by treatment with upadacitinib plus methotrexate (DOPPLER study): Study protocol for an interventional, multicenter, open-label and single-arm clinical trial with clinical, ultrasound and biomarker assessments
- Rheumatoid arthritis
- Kawakami Atsushi
- 2021-01-12
Other
- Docetaxel and S-1 as adjuvant chemotherapy for pathological stage II, IIIA, IIIB gastric cancer
- Pathological stage II, IIIa, or IIIb gastric cancer
- Dept. of Surgery and Science, Kyushu University
- 2007-10-19
Other
- Docetaxel in combination with either cisplatin (DC) or gemcitabine (DG) in unresectable non-small sell lung carcinoma (NSCLC)
- Non-small sell lung carcinoma (NSCLC)
- The Tokyo cooperative oncology group
- 2006-01-23
Other
- Docetaxel(D) versus docetaxel plus gemcitabine(DG) for second-line treatment of non-small cell lung cancer (NSCLC) : Results of a JCOG randomized trial (JCOG0104)
- Non-small cell Lung Cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-07-22
Other
- Dose-intensive weekly combination chemotherapy (cisplatin, vincristine, doxorubicin and etoposide) followed by cisplatin-etoposide therapy with concurrent thoracic irradiation: evaluation of a new treatment for limited-disease small-cell lung cancer.
- limited-disease small-cell lung cancer
- West Japan Oncology Group
- 2005-09-09
Other
- Double-blind Placebo-controlled Phase III Clinical Trial of TAP-144-SR (3M) in Patients with Spinal and Bulbar Muscular Atrophy (SBMA)
- Spinal and Bulbar Muscular Atrophy(SBMA)
- Center for Clinical Trials, Japan Medical Association
- 2006-09-05